Celgene’s most recent trend suggests a bearish bias. One trading opportunity on Celgene is a Bear Call Spread using a strike $165.00 short call and a strike $175.00 long call offers a potential 19.33% return on risk over the next 23 calendar days. Maximum profit would be generated if the Bear Call Spread were to expire worthless, which would occur if the stock were below $165.00 by expiration. The full premium credit of $1.62 would be kept by the premium seller. The risk of $8.38 would be incurred if the stock rose above the $175.00 long call strike price.
The 5-day moving average is moving down which suggests that the short-term momentum for Celgene is bearish and the probability of a decline in share price is higher if the stock starts trending.
The 20-day moving average is moving down which suggests that the medium-term momentum for Celgene is bearish.
The RSI indicator is at 51.15 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Celgene
Weekly Review Stocks React To Q3 Earnings Reports
Thu, 24 Oct 2013 23:00:00 GMT
Investor’s Business Daily – Weekly Review Stocks React To Q3 Earnings Reports
Celgene, Alexion Q3 Profit Beat Views
Thu, 24 Oct 2013 20:52:00 GMT
Investor’s Business Daily – Inside Real Estate/Staff, New Issue America/New Issue Pipeline, Industry Snapshot/Default, New Issue America/Default, Making Money/Investor’s Corner, Front Page News/Feature Story, Front Page News/General …
Celgene’s MM-020 shows positive safety benefit for Revlimid, says RBC Capital
Thu, 24 Oct 2013 19:36:47 GMT
theflyonthewall.com – RBC Capital said a letter from Spring 2013 from Celgene to EU physicians reports that interim analysis of M -020 showed positive safety benefit for Revlimid on secondary primary malignancies. The firm …
Celgene Earnings Grow Year over Year, View Upped
Thu, 24 Oct 2013 17:35:03 GMT
Zacks – Celgene’s earnings grew 17.5% in the third quarter of 2013.
Celgene 3Q net income slips on higher expenses
Thu, 24 Oct 2013 17:07:41 GMT
Also on Market Tamer…
Follow Us on Facebook